|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C12N 15/13 | |||
| C12N 15/63 | |||
| A61P 35/00 | |||
| C07K 16/32 | |||
| A61K 39/00 | |||
| C07K 16/30 |
| (11) | Patento numeris | 2540745 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10846324.1 |
| Europos patento paraiškos padavimo data | 2010-04-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-09-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2010/000511 |
| Data | 2010-04-16 |
| (87) | Numeris | WO 2011/103700 |
| Data | 2011-09-01 |
| (30) | Numeris | Data | Šalis |
| 201010125241 | 2010-02-25 | CN |
| (72) |
LI, Chuan, CN
TONG, Xin, CN
KAN, Ying, CN
|
| (73) |
Shanghai Biomabs Pharmaceuticals Co., Ltd,
No. 301, Libing Road, Pudong District Shanghai 201203,
CN
|
| (54) | FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF |
| FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF |